Metropolis Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare reported strong FY2026 results with consolidated revenue growing 23.6% to Rs. 1,64,585 lakhs from Rs. 1,33,120 lakhs in FY2025. Profit after tax rose 31.4% to Rs. 19,118 lakhs from Rs. 14,551 lakhs. Q4 standalone revenue was Rs. 35,203 lakhs with PAT of Rs. 4,324 lakhs. The board declared a 2nd interim dividend of Rs. 1 per share (record date May 19, 2026), adding to the Rs. 4 per share already paid in November 2025. Exceptional items of Rs. 899 lakhs relate to the implementation of new Labour Codes. The company is changing statutory auditors from B S R & Co. LLP to Deloitte Haskins & Sells, subject to shareholder approval. An income tax demand matter (originally Rs. 7,306 lakhs, reduced to Rs. 3,880 lakhs) is pending before ITAT. The company completed three acquisitions during the year for a total of Rs. 11,611 lakhs.
Strong double-digit revenue and PAT growth with clean audit opinion is positive for shareholders. The dividend and bonus share issuance (3:1 ratio) provide direct shareholder returns. The auditor change and ongoing tax litigation are notable but not alarming.